Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 3/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8872520 | 0.93 | CHRM2 (0.46) | CHRM1CHRM2CHRM4CHRM3 | |
| Oxalic Acid SCHEMBL6626814 | 0.85 | CHRM2 (0.54) | CHRM1CHRM2CHRM4CHRM3 | |
| Oxalic Acid SCHEMBL7430916 | 0.84 | CHRM1 (0.41) | CHRM1CHRM2CHRM4CHRM3 | |
| Oxalic Acid SCHEMBL7427776 | 0.81 | CHRM2 (0.64) | CHRM1CHRM2CHRM4CHRM3 | |
| Oxalic Acid SCHEMBL7427781 | 0.81 | CHRM2 (0.64) | CHRM1CHRM2CHRM4CHRM3 | |
| Oxalic Acid SCHEMBL6628862 | 0.77 | CHRM2 (0.52) | CHRM1CHRM2CHRM4CHRM3 | |
| SCHEMBL12043252 | 0.76 | CHRM2 (0.60) | CHRM1CHRM2CHRM4CHRM3 | |
| SCHEMBL6627286 | 0.76 | CHRM2 (0.60) | CHRM1CHRM2CHRM4CHRM3 | |
| SCHEMBL7424970 | 0.72 | CHRM2 (0.72) | CHRM1CHRM2CHRM4CHRM3 | |
| SCHEMBL7424972 | 0.72 | CHRM2 (0.72) | CHRM1CHRM2CHRM4CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE35593-E | THERAPY FOR DERMENTIA | BEECHAM GROUP P.L.C. | 1997-08-19 | — | — | US | disclosed |
| US-5278170-A | Azabicylo oxime compounds | BEECHAM GROUP P.L.C. (GB) | 1994-01-11 | — | — | US | disclosed |
| EP-0392803-A1 | Novel compounds | Beecham Group p.l.c. (GB) | 1990-10-17 | — | — | EP | disclosed |